CHAMPION-AF Clinical Trial
NCT: NCT04394546 · ACTIVE_NOT_RECRUITING
광고
NCT IDNCT04394546
상태ACTIVE_NOT_RECRUITING
시작일2020-10-15
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated
간략 요약
The primary objective of this study is to determine if left atrial appendage closure (LAAC) with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.